Prothena Corp Public (PRTA) Current Deferred Tax Assets (2012 - 2015)
Prothena Corp Public (PRTA) recorded quarterly Current Deferred Tax Assets of $174000.0 in Q3 2015, up 5.45% quarter-over-quarter from $165000.0 in Q2 2015, and up 95.51% on a YoY basis from $89000.0 in Q3 2014.
Prothena Corp Public (PRTA) Current Deferred Tax Assets (2012 - 2015) Analysis & Trends
Prothena Corp Public's Current Deferred Tax Assets history runs 4 years deep, the most recent figure standing at $174000.0 for Q3 2015.
- In Q3 2015, Current Deferred Tax Assets rose 95.51% year-over-year to $174000.0; the TTM figure through Sep 2015 stood at $174000.0 (up 95.51% YoY), while the FY2014 annual figure was $167000.0, up 106.17% from the prior year.
- Current Deferred Tax Assets was $174000.0 for Q3 2015 at Prothena Corp Public, up from $165000.0 in the prior quarter.
- In the past five years, Current Deferred Tax Assets ranged from a high of $267000.0 in Q3 2013 to a low of $73000.0 in Q4 2012.
- Historically, Current Deferred Tax Assets has averaged $123666.7 across 4 years, with a median of $85500.0 in 2014.
- The sharpest annual moves came in 2014 and 2015: Current Deferred Tax Assets slumped 66.67% in 2014, then soared 111.69% in 2015.
- A 4-year view of Current Deferred Tax Assets shows it stood at $73000.0 in 2012, then gained by 10.96% to $81000.0 in 2013, then surged by 106.17% to $167000.0 in 2014, then grew by 4.19% to $174000.0 in 2015.
- The last three Current Deferred Tax Assets figures came in at $174000.0 (Q3 2015), $165000.0 (Q2 2015), and $163000.0 (Q1 2015), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Prothena Corp Public | 479.08 Mn | 149.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 174,000.00 |
| Sep 30, 2015 | 174,000.00 |
| Jun 30, 2015 | 165,000.00 |
| Jun 30, 2015 | 165,000.00 |
| Mar 31, 2015 | 163,000.00 |
| Mar 31, 2015 | 163,000.00 |
| Dec 31, 2014 | 167,000.00 |
| Dec 31, 2014 | 167,000.00 |
| Sep 30, 2014 | 89,000.00 |
| Sep 30, 2014 | 89,000.00 |
| Jun 30, 2014 | 82,000.00 |
| Jun 30, 2014 | 82,000.00 |
| Mar 31, 2014 | 77,000.00 |
| Mar 31, 2014 | 77,000.00 |
| Dec 31, 2013 | 81,000.00 |
| Dec 31, 2013 | 81,000.00 |
| Sep 30, 2013 | 267,000.00 |
| Sep 30, 2013 | 267,000.00 |
| Jun 30, 2013 | 73,000.00 |
| Jun 30, 2013 | 73,000.00 |